Lv1
70 积分 2022-08-16 加入
RNF43 is frequently mutated in colorectal and endometrial cancers
12天前
已完结
Mutational processes shape the landscape of TP53 mutations in human cancer
20天前
已完结
Efficacy and Tolerability of Osimertinib and Sotorasib Combination Treatment for Osimertinib Resistance Caused by KRAS G12C Mutation: A Report of Two Cases
25天前
已完结
Molecular characterization of KRAS wild type tumors in patients with pancreatic adenocarcinoma
26天前
已完结
Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial
1个月前
已完结
Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas
1个月前
已完结
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
1个月前
已完结
PIcKing on Fibroblast Growth Factor Receptors as Bladder Cancer Therapeutic Targets
1个月前
已关闭
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
1个月前
已完结
Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer
2个月前
已完结
皖公网安备34019202002308
